Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia
Clinical trial NCT03582085 · WITHDRAWN
Trial details
- NCT number
- NCT03582085
- Sponsor
- Massachusetts General Hospital
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2027-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.